help button home button Endocrine Society Endocrinology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Fehmann, H. C.
Right arrow Articles by Habener, J. F.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Fehmann, H. C.
Right arrow Articles by Habener, J. F.

Endocrinology, Vol 128, 2880-2888, Copyright © 1991 by Endocrine Society


ARTICLES

Homologous desensitization of the insulinotropic glucagon-like peptide- I (7-37) receptor on insulinoma (HIT-T15) cells

HC Fehmann and JF Habener
Laboratory of Molecular Endocrinology, Massachusetts General Hospital, Boston 02114.

Glucagon-like peptide-I(7-37) [GLP-I(7-37)] is an intestinal peptide with potent insulinotropic activities on pancreatic beta-cells in vivo and in vitro. In earlier studies elevated concentrations GLP-I(7-37) inhibited insulin release and cAMP generation in beta-cells. We now show that the GLP-I(7-37) receptor in the glucose-responsive B-cell line HIT-T15 undergoes rapid and reversible homologous desensitization in response to supraphysiological concentrations of GLP-I(7-37). GLP- I(7-37) stimulated insulin release and cAMP generation in a glucose- dependent biphasic manner with a maximum stimulation at 10 nmol/liter. The first-phase insulin secretory response was reduced by 41% at doses of GLP-I(7-37) of 100 nmol/liter and higher. Preperifusion of B-cells with 100 nmol/liter GLP-I(7-37) for 5 or 10 min reduced a subsequent insulin secretory response to 10 nmol/liter GLP-I(7-37) after hormone washout and recovery periods of 10 min (52% and 55% reduction) or 30 min (33% reduction or full recovery). Preperifusion of HIT-T15 cells with 100 nmol/liter glucagon (10 min) or 100 nmol/liter gastric inhibitory peptide (GIP) (10 min) had no effect on the insulin secretory response to 10 nmol/liter GLP-(7-37). Prior exposure of cells to 100 nmol/liter GLP-(7-37) (10 min) did not alter the GIP-induced (10 nmol/liter) insulin release, but 100 nmol/liter GIP (10 min) reduced the insulin secretion during stimulation with 10 nmol/liter GIP by 56%. These data indicate that: 1) the GLP-I(7-37) receptor is subject to rapid and reversible homologous desensitization and, 2) the GLP-I(7-37) receptor on beta-cells is distinct from that of GIP. The recent finding of elevated GLP-I(7-36)amide levels in subjects with noninsulin- dependent diabetes suggest the possibility that a homologous desensitization of the GLP-I(7-37) receptor might contribute to the impaired insulin secretion in this disorder.


This article has been cited by other articles:


Home page
DiabetesHome page
L. L. Baggio, J.-G. Kim, and D. J. Drucker
Chronic Exposure to GLP-1R Agonists Promotes Homologous GLP-1 Receptor Desensitization In Vitro but Does Not Attenuate GLP-1R-Dependent Glucose Homeostasis In Vivo
Diabetes, December 1, 2004; 53(suppl_3): S205 - S214.
[Abstract] [Full Text] [PDF]


Home page
J. Physiol.Home page
S. A. Hinke, K. Hellemans, and F. C. Schuit
Plasticity of the {beta} cell insulin secretory competence: preparing the pancreatic {beta} cell for the next meal
J. Physiol., July 15, 2004; 558(2): 369 - 380.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
N. A. Walsh, B. Yusta, M. P. DaCambra, Y. Anini, D. J. Drucker, and P. L. Brubaker
Glucagon-Like Peptide-2 Receptor Activation in the Rat Intestinal Mucosa
Endocrinology, October 1, 2003; 144(10): 4385 - 4392.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Endocrinol. Metab.Home page
T. Niwa, Y. Nimura, and I. Niki
Lack of effect of incretin hormones on insulin release from pancreatic islets in the bile duct-ligated rats
Am J Physiol Endocrinol Metab, January 1, 2001; 280(1): E59 - E64.
[Abstract] [Full Text] [PDF]


Home page
Endocr. Rev.Home page
T. J. Kieffer and J. Francis Habener
The Glucagon-Like Peptides
Endocr. Rev., December 1, 1999; 20(6): 876 - 913.
[Abstract] [Full Text]


Home page
Ann. N. Y. Acad. Sci.Home page
S. EMAMI, K. REGNAULD, N. FERRAND, A. ASTESANO, M. PESSAH, H. PHAN, C. BOISSARD, J.-M. GAREL, and G. ROSSELIN
Stimulatory Transducing Systems in Pancreatic Islet Cells
Ann. N.Y. Acad. Sci., December 11, 1998; 865(1): 118 - 131.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
G. G. Holz, IV, C. A. Leech, and J. F. Habener
Activation of a cAMP-regulated Ca[IMAGE]-Signaling Pathway in Pancreatic [IMAGE]-Cells by the Insulinotropic Hormone Glucagon-like Peptide-1
J. Biol. Chem., July 28, 1995; 270(30): 17749 - 17757.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
L. Baggio, F. Adatia, T. Bock, P. L. Brubaker, and D. J. Drucker
Sustained Expression of Exendin-4 Does Not Perturb Glucose Homeostasis, beta -Cell Mass, or Food Intake in Metallothionein-Preproexendin Transgenic Mice
J. Biol. Chem., October 27, 2000; 275(44): 34471 - 34477.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 1991 by The Endocrine Society